3651 results for «276»
3651 results
Challenges in treating tricuspid regurgitation
22 May 2026 – From EuroPCR 2026
This session addresses the complexities of treating tricuspid regurgitation, offering insights into tailored treatment options and complication management. Through detailed case studies from China and Germany, it highlights practical approaches and bailout strategies for tricuspid valve interventions.
How to treat aortic regurgitation
22 May 2026 – From EuroPCR 2026
Explore cutting-edge transcatheter approaches for aortic regurgitation, including first-in-human ATLAS technique, management in LVAD patients, and off-label Myval use. This session reviews clinical challenges and innovative solutions in aortic valve interventions, offering valuable insights from complex procedural experiences.
Left main PCI: predictions of risk and long-term clinical outcome
22 May 2026 – From EuroPCR 2026
This session focuses on risk prediction and long-term outcomes following left main percutaneous coronary intervention (PCI). It covers biomarkers like NT-proBNP, hemodynamic predictors, and the impact of comorbidities such as diabetes and chronic kidney disease on patient prognosis over a ten-year follow-up.
Right-sided interventions and impact on the right heart
22 May 2026 – From EuroPCR 2026
This session examines right-sided cardiac interventions and their impact on right heart function. Topics include prognostic implications of right ventricular wall tension, novel metrics for RV-PA coupling, clinical effects of severe tricuspid regurgitation, and strategies for transcatheter pulmonary valve replacement in complex right ventricular outflow tract...
Technical decision-making for CTO PCI strategy
22 May 2026 – From EuroPCR 2026
This session focuses on technical decision-making for chronic total occlusion PCI strategy. It presents diverse approaches to right coronary CTOs, complex management involving double rendezvous techniques, subintimal strategies, and innovative single-injection methods, demonstrating the evolving frontiers in CTO intervention.
Challenging PCI on bifurcation lesions
22 May 2026 – From EuroPCR 2026
Addressing the complexities of PCI in bifurcation lesions, this session highlights novel techniques such as the TAP and modified mini-crush methods, alongside strategies for managing challenging coronary anatomy. Validation of novel approaches like POT-side DCB-POT for left main bifurcations is also featured.
Unusual clinical cases: thinking beyond the routine
22 May 2026 – From EuroPCR 2026
This session presents unusual and challenging clinical cases that extend beyond routine interventional cardiology. From optimised in-stent restenosis treatment to rare anatomical anomalies and complex thrombus management, it offers valuable lessons in creative problem-solving and advanced intervention techniques.
Management of uncommon TAVI complications
21 May 2026 – From EuroPCR 2026
This session delves into the management of uncommon but critical complications arising from Transcatheter Aortic Valve Implantation (TAVI). Through detailed case studies from Italy, Lebanon, and Turkey, it highlights real-time decision-making strategies for life-threatening scenarios including left ventricular outflow tract obstruction, acute aortic dissection, and complex...
Spontaneous coronary artery dissection management with intracoronary imaging
22 May 2026 – From EuroPCR 2026
Explore the nuanced management of spontaneous coronary artery dissection (SCAD) with a focus on intracoronary imaging. This session examines diagnostic challenges, the limited role of coronary CT angiography, and strategies for managing occlusive SCAD cases, highlighting the evolving understanding of this complex condition.
Atypical NSTEMI culprit lesions
22 May 2026 – From EuroPCR 2026
Focusing on atypical NSTEMI culprit lesions, this session examines rare presentations such as calcific emboli, coronary anomalies, and unusual routes to revascularisation. It provides clinical insights into diagnosing and managing uncommon acute coronary syndromes effectively.
Updates in tricuspid TEER
21 May 2026 – From EuroPCR 2026
This session offers comprehensive updates on transcatheter edge-to-edge repair (TEER) for tricuspid valve disease. It reviews meta-analyses on outcomes in patients with cardiac implantable electronic device leads, long-term trial results, echocardiographic and clinical outcomes, right ventricular mechanics, risk scoring, and the impact of renal function and...
Spectrum of cardiogenic shock
21 May 2026 – From EuroPCR 2026
This session delves into the broad spectrum of cardiogenic shock phenotypes, emphasizing the importance of selecting appropriate left ventricular support tailored to specific clinical scenarios. It offers critical insights into the timing of mechanical circulatory support and revascularisation strategies to optimize patient outcomes.
CT and intracoronary imaging evaluation of coronary disease
21 May 2026 – From EuroPCR 2026
This session focuses on advanced imaging modalities for evaluating coronary artery disease, including the clinical application of CT angiography and intracoronary imaging techniques like OCT and IVUS. Topics encompass barriers to OCT usage, the impact of plaque composition on PCI outcomes, advances in photon-counting CT technology,...
Controversies and conversations in TAVI
21 May 2026 – From EuroPCR 2026
This session addresses key controversies and discussions in transcatheter aortic valve implantation (TAVI), including the role of invasive coronary angiography prior to TAVI, use of cangrelor during combined TAVI and high-risk PCI, and discrepancies in aortic valve stenosis assessment methods. Additional topics cover operator models, valve...
Calcified lesions: when one dedicated device is not enough
22 May 2026 – From EuroPCR 2026
This session highlights the need for multiple dedicated devices in the treatment of calcified coronary lesions. It discusses combined orbital and rotational atherectomy techniques, debulking in complex high-risk patients, and the integration of atherectomy with intravascular lithotripsy systems. Emphasis is placed on physiology and imaging-guided approaches...
Diagnosis and management of INOCA and ANOCA
21 May 2026 – From EuroPCR 2026
This session focuses on the diagnosis and management of ischemia and angina with non-obstructive coronary arteries (INOCA and ANOCA). It presents safety data from coronary function testing, patient outcomes after comprehensive ischemia assessment, and endotype-specific treatment effects. Further topics include coronary sinus reducer therapy, the impact...
Left main PCI
21 May 2026 – From EuroPCR 2026
This session addresses the complexities of percutaneous coronary intervention (PCI) involving the left main coronary artery. It features challenging clinical cases including acute total occlusion with cardiogenic shock, innovative techniques like the inverted Double TAP for trifurcations, mechanical circulatory support integration, management of stent complications, and...
TAVI procedural challenges
21 May 2026 – From EuroPCR 2026
This session examines procedural challenges encountered during Transcatheter Aortic Valve Implantation (TAVI), especially in complex anatomical and clinical contexts. Topics include TAVI after prior mitral valve procedures, combined use of left ventricular assist devices and rotablation, navigating challenging aortic anatomies, and managing extensive calcification. The session...
Challenges of multivessel disease in ACS
21 May 2026 – From EuroPCR 2026
Dedicated to the challenges of multivessel disease in acute coronary syndrome (ACS), this session explores strategies to identify culprit versus non-culprit lesions and plan multivessel revascularisation using physiology, intravascular imaging, and artificial intelligence. It further discusses the timing considerations for revascularisation, whether ad-hoc or staged, illustrated...
Innovative strategies in STEMI management
22 May 2026 – From EuroPCR 2026
This session presents innovative strategies in STEMI management, including the treatment of acute saphenous vein graft occlusion, primary PCI via the left internal mammary artery, and a two-step lesion debulking approach. It also covers hybrid drug-coated balloon strategies in complex multivessel disease and the emerging role...